Soleno Therapeutics
SLNO
#4435
Rank
A$3.47 B
Marketcap
A$64.79
Share price
2.94%
Change (1 day)
-17.24%
Change (1 year)

Earnings for Soleno Therapeutics (SLNO)

Earnings in 2025 (TTM): -A$0.12 Billion

According to Soleno Therapeutics's latest financial reports the company's current earnings are A$98.67 Million. In 2024 the company made an earning of -A$0.26 Billion a decrease over its 2023 earnings that were of -A$57.3 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Soleno Therapeutics from 2013 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$0.12 Billion-55.53%
2024 -A$0.26 Billion339.22%
2023 -A$57.3 Million54.01%
2022 -A$37.21 Million-22.16%
2021 -A$47.8 Million0.97%
2020 -A$47.34 Million37.73%
2019 -A$34.37 Million96.94%
2018 -A$17.46 Million21.69%
2017 -A$14.35 Million-23.69%
2016 -A$18.8 Million-20.82%
2015 -A$23.74 Million86%
2014 -A$12.76 Million829.91%
2013 -A$1.38 Million